Cita APA

Wyse, J. J., Morasco, B. J., Dobscha, S. K., Demidenko, M. I., Meath, T. H. A., & Lovejoy, T. I. (2018). Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified. J Opioid Manag.

Citación estilo Chicago

Wyse, Jessica J., Benjamin J. Morasco, Steven K. Dobscha, Michael I. Demidenko, Thomas H. A. Meath, y Travis I. Lovejoy. "Provider Reasons for Discontinuing Long-term Opioid Therapy Following Aberrant Urine Drug Tests Differ Based On the Type of Substance Identified." J Opioid Manag 2018.

Cita MLA

Wyse, Jessica J., et al. "Provider Reasons for Discontinuing Long-term Opioid Therapy Following Aberrant Urine Drug Tests Differ Based On the Type of Substance Identified." J Opioid Manag 2018.